These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 18806632)
1. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632 [TBL] [Abstract][Full Text] [Related]
2. Inter-regional comparisons of the prevalence of cardiometabolic risk factors in patients with hypertension in Europe: the GOOD survey. Farsang C; Naditch-Brule L; Perlini S; Zidek W; Kjeldsen SE; J Hum Hypertens; 2009 May; 23(5):316-24. PubMed ID: 19005476 [TBL] [Abstract][Full Text] [Related]
3. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey. Kabakcı G; Aydın M; Demir I; Kırma C; Özerkan F Turk Kardiyol Dern Ars; 2010 Jul; 38(5):313-20. PubMed ID: 21200100 [TBL] [Abstract][Full Text] [Related]
4. The metabolic syndrome among postmenopausal women in Ecuador. Hidalgo LA; Chedraui PA; Morocho N; Alvarado M; Chavez D; Huc A Gynecol Endocrinol; 2006 Aug; 22(8):447-54. PubMed ID: 17012107 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima-media thickness. Zanchetti A; Hennig M; Baurecht H; Tang R; Cuspidi C; Carugo S; Mancia G J Hypertens; 2007 Dec; 25(12):2463-70. PubMed ID: 17984668 [TBL] [Abstract][Full Text] [Related]
6. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
8. Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. Mancia G; Parati G; Borghi C; Ghironzi G; Andriani E; Marinelli L; Valentini M; Tessari F; Ambrosioni E; J Hypertens; 2006 May; 24(5):837-43. PubMed ID: 16612244 [TBL] [Abstract][Full Text] [Related]
9. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions. Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328 [TBL] [Abstract][Full Text] [Related]
10. Association of metabolic risk factors with uncontrolled hypertension: comparison of the several definitions of metabolic syndrome. Cortez-Dias N; Martins SR; Belo A; Fiuza M; J Hypertens; 2013 Oct; 31(10):1991-7. PubMed ID: 23811998 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria. Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722 [TBL] [Abstract][Full Text] [Related]
12. Influence of metabolic syndrome on risk stratification in hypertensive patients: differences between 2003 and 2007 ESH-ESC guidelines. Martell N; Alvarez-Alvarez B; Fernandez-Cruz A Ther Adv Cardiovasc Dis; 2010 Apr; 4(2):97-103. PubMed ID: 20200202 [TBL] [Abstract][Full Text] [Related]
13. Pulse pressure and heart rate in patients with metabolic syndrome across Europe: insights from the GOOD survey. Perlini S; Naditch-Brule L; Farsang C; Zidek W; Kjeldsen SE J Hum Hypertens; 2013 Jul; 27(7):412-6. PubMed ID: 23235366 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting. Neira CP; Hartig M; Cowan PA; Velasquez-Mieyer PA J Am Acad Nurse Pract; 2009 Mar; 21(3):173-8. PubMed ID: 19302694 [TBL] [Abstract][Full Text] [Related]
15. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study. Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS; Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008 [TBL] [Abstract][Full Text] [Related]
16. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378 [TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism in patients with essential hypertension. García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R; Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774 [TBL] [Abstract][Full Text] [Related]
18. Assessment and management of hypertension in patients with type 2 diabetes. Thomas MC; Atkins R Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428 [TBL] [Abstract][Full Text] [Related]
19. Association of metabolic syndrome with microalbuminuria in non-hypertensive type 2 diabetic patients. Lee JE; Huh W; Son HJ; Kim YG; Kim DJ; Lee MK; Oh HY Nephron Clin Pract; 2007; 106(3):c98-103. PubMed ID: 17522477 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]